SCHEMBL6935548

SCHEMBL6935548

COc1ccc(C(=O)Nc2c(C)cccc2C)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
F10 P00742 2/20 0.63
NPC1 O15118 7/20 0.62
RAB9A P51151 7/20 0.62
TP53 P04637 4/20 0.62
SMN1; SMN2 Q16637 4/20 0.62
ALOX15 P16050 1/20 0.62
NFKB1 P19838 1/20 0.61
NFKB2 Q00653 1/20 0.61
RELA Q04206 1/20 0.61
KMT2A Q03164 4/20 0.60
PKM P14618 1/20 0.60
KCNK9 Q9NPC2 1/20 0.59
KCNK3 O14649 1/20 0.57
MEN1 O00255 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
GAA P10253 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21870513 0.91 ALDH1A1 (0.59) ALDH1A1F10NPC1RAB9ATP53
SCHEMBL7249253 0.91 F10 (0.69) ALDH1A1F10NPC1RAB9ATP53
SCHEMBL15775332 0.87 ALDH1A1 (0.55) ALDH1A1F10NPC1RAB9ATP53
SCHEMBL31465694 0.84 CES2 (0.55) ALDH1A1F10NPC1RAB9ATP53
SCHEMBL9523014 0.82 S1PR4 (0.69) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL8832040 0.82 F10 (0.81) ALDH1A1F10NPC1RAB9ATP53
SCHEMBL9522743 0.81 S1PR4 (0.58) ALDH1A1NPC1RAB9ATP53KMT2A
SCHEMBL4138460 0.80 POLB (0.67) NPC1RAB9ASMN1; SMN2KMT2AKCNK9
SCHEMBL5221661 0.80 TP53 (0.62) F10NPC1RAB9ATP53SMN1; SMN2
Ameltolide SCHEMBL635392 0.79 S1PR4 (0.56) ALDH1A1SMN1; SMN2KMT2APKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0279633-B1 ANTICONVULSANT AGENTS ELI LILLY AND COMPANY (US) 1993-04-07 EP claimed
EP-0279633-A2 Anticonvulsant agents ELI LILLY AND COMPANY (US) 1988-08-24 EP claimed
EP-1268051-A2 DOSING FORM FOR REAGENTS, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND PRODUCTION OF SAID DOSING FORM H. Lundbeck A/S (DK) 2003-01-02 EP disclosed
WO-2001068599-A2 DOSING FORM FOR REAGENTS, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND PRODUCTION OF SAID DOSING FORM H. LUNDBECK A/S (DK) 2001-09-20 WO disclosed
EP-0279633-B1 ANTICONVULSANT AGENTS ELI LILLY AND COMPANY (US) 1993-04-07 EP disclosed
US-4981866-A BENZAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1991-01-01 US disclosed
US-4939163-A 4-substituted benzamide derivatives ELI LILLY AND COMPANY (US) 1990-07-03 US disclosed
US-4835181-A Anticonvulsant agents using cyano dimethylphenyl benzamides ELI LILLY AND COMPANY (US) 1989-05-30 US disclosed
EP-0279633-A2 Anticonvulsant agents ELI LILLY AND COMPANY (US) 1988-08-24 EP disclosed